abstract |
The present invention relates to a series of compounds useful for inhibiting the enzymatic activity of histone deacetylase (HDAC). The present invention also provides a method for inhibiting histone deacetylase in cells using the compound, and a method for treating cell proliferative diseases and conditions using the HDAC inhibitor. Furthermore, the present invention provides a pharmaceutical composition comprising a compound that inhibits HDAC and a pharmaceutically acceptable carrier. |